T. Rowe Price Investment Management’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-276,369
Closed -$7M 626
2024
Q2
$7M Sell
276,369
-1,168,748
-81% -$29.6M ﹤0.01% 558
2024
Q1
$44.7M Buy
1,445,117
+9,837
+0.7% +$304K 0.03% 412
2023
Q4
$57.9M Buy
1,435,280
+439,648
+44% +$17.7M 0.04% 370
2023
Q3
$26.3M Buy
+995,632
New +$26.3M 0.02% 451